DUBLIN, Feb. 12, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/l8796k/global_wound) has announced the addition of the "Global Wound Biologics Market 2016-2020" report to their offering.
This comprehensive report predicts the global wound biologics market will grow with a CAGR of 20.63% during the 2016-2020 period.
Commenting on the report, an analyst from the research team said: The growth of this market is driven by the rising demand for various biologics in advanced wound care segment. Products such as allografts and autografts have high efficacy rates, and these are used for healing chronic wounds such as diabetic foot ulcers and venous ulcers. The availability of a broad range of approved skin substitutes such as grafts, tissue scaffolds, and cell-based therapies are expected to increase its demand from physicians and patients during the forecast period.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Questions Answered:
Companies Mentioned:
Report Structure:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by product
PART 07: Geographical segmentation
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges
PART 11: Impact of drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
PART 14: Appendix
PART 15: About the Author
For more information visit http://www.researchandmarkets.com/research/l8796k/global_wound
Media Contact:
Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets
Share this article